- Home
- CGTX vs OXBR Comparison
CGTX vs OXBR Comparison
Compare CGTX & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- OXBR
- Stock Information
- Founded
- CGTX 2007
- OXBR 2013
- Country
- CGTX United States
- OXBR Cayman Islands
- Employees
- CGTX N/A
- OXBR N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- OXBR Property-Casualty Insurers
- Sector
- CGTX Health Care
- OXBR Finance
- Exchange
- CGTX Nasdaq
- OXBR Nasdaq
- Market Cap
- CGTX 16.1M
- OXBR 18.6M
- IPO Year
- CGTX 2021
- OXBR 2014
- Fundamental
- Price
- CGTX $0.63
- OXBR $3.89
- Analyst Decision
- CGTX Strong Buy
- OXBR
- Analyst Count
- CGTX 6
- OXBR 0
- Target Price
- CGTX $8.30
- OXBR N/A
- AVG Volume (30 Days)
- CGTX 20.0M
- OXBR 35.9K
- Earning Date
- CGTX 11-13-2024
- OXBR 11-13-2024
- Dividend Yield
- CGTX N/A
- OXBR N/A
- EPS Growth
- CGTX N/A
- OXBR N/A
- EPS
- CGTX N/A
- OXBR N/A
- Revenue
- CGTX N/A
- OXBR N/A
- Revenue This Year
- CGTX N/A
- OXBR N/A
- Revenue Next Year
- CGTX N/A
- OXBR N/A
- P/E Ratio
- CGTX N/A
- OXBR N/A
- Revenue Growth
- CGTX N/A
- OXBR N/A
- 52 Week Low
- CGTX $0.34
- OXBR $0.87
- 52 Week High
- CGTX $2.95
- OXBR $4.19
- Technical
- Relative Strength Index (RSI)
- CGTX 69.18
- OXBR 62.04
- Support Level
- CGTX $0.43
- OXBR $3.62
- Resistance Level
- CGTX $1.29
- OXBR $4.07
- Average True Range (ATR)
- CGTX 0.10
- OXBR 0.31
- MACD
- CGTX 0.03
- OXBR -0.02
- Stochastic Oscillator
- CGTX 27.88
- OXBR 47.78
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.